Search
Free Newsletters
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
About
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
NVDA
+0.54%
$111.53
+$0.60
NYT
+0.29%
$48.62
+$0.14
JPM
-0.63%
$234.72
-$1.48
GOOGL
+1.23%
$159.07
+$1.93
TSLA
+1.13%
$255.15
+$2.84
NWSA
+0.71%
$26.38
+$0.19
WMT
+2.60%
$95.21
+$2.41
AMZN
-1.08%
$182.88
-$1.99
CMCSA
+1.99%
$34.39
+$0.67
MSFT
+0.24%
$389.39
+$0.94
NVDA
+0.54%
$111.53
+$0.60
NYT
+0.29%
$48.62
+$0.14
JPM
-0.63%
$234.72
-$1.48
GOOGL
+1.23%
$159.07
+$1.93
TSLA
+1.13%
$255.15
+$2.84
NWSA
+0.71%
$26.38
+$0.19
WMT
+2.60%
$95.21
+$2.41
AMZN
-1.08%
$182.88
-$1.99
CMCSA
+1.99%
$34.39
+$0.67
MSFT
+0.24%
$389.39
+$0.94
Markets
RECENT NEWS
Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approval
March 28, 2025
Even foreign pharma companies are ditching DEI
March 19, 2025
Pfizer quietly made some big DEI changes
February 28, 2025
Biogen Inc. (BIIB) reports earnings
February 12, 2025
Advertisement